Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs

Molecular Psychiatry

Volumn 19, Issue 5, 2014, Pages 607-614

  Perez Caballero, L ^a,b   Perez Egea R ^b,c   Romero Grimaldi, C ^a,b   Puigdemont, D ^b,c   Molet, J ^c   Caso, J R ^b,d   Mico, J A ^a,b   Perez V ^b,c   Leza, J C ^b,d   Berrocoso, E ^a,b  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

deep brain stimulation; depression; non steroidal anti inflammatory drugs; subgenual cingulated gyrus

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; P11 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEPTH STIMULATION; CINGULATE GYRUS; CLIMBING; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; ELECTRODE; ELECTRODE IMPLANT; FEMALE; HUMAN; IMMOBILITY; IMMUNOREACTIVITY; INFLAMMATION; LOCOMOTION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REMISSION; RETROSPECTIVE STUDY; SWIMMING; TREATMENT RESPONSE; ADVERSE EFFECTS; ANIMAL; BRAIN CORTEX; CHRONIC DISEASE; CLINICAL TRIAL; DEPRESSIVE DISORDER, MAJOR; DISEASE MODEL; DRUG EFFECTS; IMMUNOMODULATION; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CEREBRAL CORTEX; CHRONIC DISEASE; DEEP BRAIN STIMULATION; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GYRUS CINGULI; HUMANS; MALE; NEUROIMMUNOMODULATION; RATS, WISTAR; RETROSPECTIVE STUDIES; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 84899490159     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.63     Document Type: Article

References (50)

1. Hamani C, Mayberg H, Snyder B, Giacobbe P, Kennedy S, Lozano AM. Deep brainstimulation of the subcallosal cingulate gyrus for depression: anatomical locationof active contacts in clinical responders and a suggested guideline for targeting.J Neurosurg 2009; 111: 1209-1215.
2. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH.Subcallosal cingulate gyrus deep brain stimulation for treatment- resistantdepression. Biol Psychiatry 2008; 64: 461-467.
3. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C et al. Deepbrain stimulation for treatment-resistant depression. Neuron 2005; 45: 651-660.
4. Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF et al. Threeyearoutcomes in deep brain stimulation for highly resistant obsessive-compulsivedisorder. Neuropsychopharmacology 2006; 31: 2384-2393. (Pubitemid 44607055)
5. Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D et al. Subthalamicnucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 2008;359: 2121-2134.
6. Maltete D, Chastan N, Derrey S, Debono B, Gerardin E, Lefaucheur R et al.Microsubthalamotomy effect at day 3: screening for determinants. Mov Disord2009; 24: 286-289.
7. Holtzheimer PE, Kelley ME, Gross RE, Filkowski MM, Garlow SJ, Barrocas A et al.Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar andbipolar depression. Arch Gen Psychiatry 2012; 69: 150-158.
8. Hirshler YK, Polat U, Biegon A. Intracranial electrode implantation producesregional neuroinflammation and memory deficits in rats. Exp Neurol 2010; 222:42-50.
9. Ongur D, Price JL. The organization of networks within the orbital and medialprefrontal cortex of rats, monkeys and humans. Cereb Cortex 2000; 10: 206-219. (Pubitemid 30159289)
10. Takagishi M, Chiba T. Efferent projections of the infralimbic (area 25) region of themedial prefrontal cortex in the rat: an anterograde tracer PHA-L study. Brain Res1991; 566: 26-39.
11. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Compact6th edn.Academic Press: San Diego, CA, USA, 2009.
12. Hamani C, Diwan M, Macedo CE, Brandao ML, Shumake J, Gonzalez-Lima F et al.Antidepressant-like effects of medial prefrontal cortex deep brain stimulation inrats. Biol Psychiatry 2010; 67: 117-124.
13. Alba-Delgado C, Llorca-Torralba M, Horrillo I, Ortega JE, Mico JA, Sanchez-BlazquezP et al. Chronic pain leads to concomitant noradrenergic impairment andmood disorders. Biol Psychiatry 2013; 73: 54-62.
14. Puigdemont D, Perez-Egea R, Portella MJ, Molet J, de Diego-Adelino J, Gironell Aet al. Deep brain stimulation of the subcallosal cingulate gyrus: further evidence intreatment-resistant major depression. Int J Neuropsychopharmacol 2011; 22: 1-13.
15. Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M et al.Alterations in 5-HT1B receptor function by p11 in depression-like states. Science2006; 311: 77-80. (Pubitemid 43063061)
16. Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P.Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) areattenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad SciUSA 2011; 108: 9262-9267.
17. Hamani C, Machado DC, Hipolide DC, Dubiela FP, Suchecki D, Macedo CE et al.Deep brain stimulation reverses anhedonic-like behavior in a chronic model ofdepression: role of serotonin and brain derived neurotrophic factor. Biol Psychiatry2012; 71: 30-35.
18. Scopinho AA, Scopinho M, Lisboa SF, Correa FM, Guimaraes FS, Joca SR. Acutereversible inactivation of the ventral medial prefrontal cortex induces antidepressant-like effects in rats. Behav Brain Res 2010; 214: 437-442.
19. Slattery DA, Neumann I, Cryan JF. Transient inactivation of the infralimbic cortexinduces antidepressant-like effects in the rat. J Psychopharmacol 2010; 25:1295-1303.
20. Gersner R, Toth E, Isserles M, Zangen A. Site-specific antidepressant effects ofrepeated subconvulsive electrical stimulation: potential role of brain-derivedneurotrophic factor. Biol Psychiatry 2010; 67: 125-132.
21. Hamani C, Diwan M, Isabella S, Lozano AM, Nobrega JN. Effects of differentstimulation parameters on the antidepressant-like response of medial prefrontalcortex deep brain stimulation in rats. J Psychiatr Res 2010; 44: 683-687.
22. Warner-Schmidt JL, Flajolet M, Maller A, Chen EY, Qi H, Svenningsson P et al. Roleof p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci2009; 29: 1937-1946.
23. Svenningsson P, Greengard P. p11 (S100A10)-an inducible adaptor protein thatmodulates neuronal functions. Curr Opin Pharmacol 2007; 7: 27-32.
24. Egeland M,Warner-Schmidt J, Greengard P, Svenningsson P. Co-expression of serotonin5-HT(1B) and 5-HT(4) receptors in p11 containing cells in cerebral cortex, hippocampus,caudate-putamen and cerebellum. Neuropharmacology 2011; 61: 442-450.
25. Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL et al.Glial pathology in an animal model of depression: reversal of stress-inducedcellular, metabolic and behavioral deficits by the glutamate-modulating drugriluzole. Mol Psychiatry 2010; 15: 501-511.
26. Banasr M, Duman RS. Glial loss in the prefrontal cortex is sufficient to inducedepressive-like behaviors. Biol Psychiatry 2008; 64: 863-870.
27. Gosselin RD, Gibney S, O'Malley D, Dinan TG, Cryan JF. Region specific decrease inglial fibrillary acidic protein immunoreactivity in the brain of a rat model ofdepression. Neuroscience 2009; 159: 915-925.
28. Miguel-Hidalgo JJ, Baucom C, Dilley G, Overholser JC, Meltzer HY, Stockmeier CAet al. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortexdistinguishes younger from older adults in major depressive disorder. Biol Psychiatry2000; 48: 861-873.
29. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortexin mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-13295.30 (Pubitemid 28509564)
30. Webster MJ, O'Grady J, Kleinman JE, Weickert CS. Glial fibrillary acidic proteinmRNA levels in the cingulate cortex of individuals with depression, bipolardisorder and schizophrenia. Neuroscience 2005; 133: 453-461. (Pubitemid 40726212)
31. Jansson L, Wennstrom M, Johanson A, Tingstrom A. Glial cell activation inresponse to electroconvulsive seizures. Prog Neuropsychopharmacol Biol Psychiatry2009; 33: 1119-1128.
32. Kragh J, Bolwig TG, Woldbye DP, Jorgensen OS. Electroconvulsive shock andlidocaine-induced seizures in the rat activate astrocytes as measured by glialfibrillary acidic protein. Biol Psychiatry 1993; 33: 794-800. (Pubitemid 23234630)
33. Czeh B, Simon M, Schmelting B, Hiemke C, Fuchs E. Astroglial plasticity in thehippocampus is affected by chronic psychosocial stress and concomitant fluoxetinetreatment. Neuropsychopharmacology 2006; 31: 1616-1626. (Pubitemid 44106693)
34. Liu Q, Li B, Zhu HY, Wang YQ, Yu J, Wu GC. Clomipramine treatment reversed theglial pathology in a chronic unpredictable stress-induced rat model of depression.Eur Neuropsychopharmacol 2009; 19: 796-805.
35. De Leon M, Van Eldik LJ, Shooter EM. Differential regulation of S100 beta andmRNAs coding for S100-like proteins (42A and 42C) during development andafter lesion of rat sciatic nerve. J Neurosci Res 1991; 29: 155-162.
36. Gveric D, Herrera BM, Cuzner ML. tPA receptors and the fibrinolytic response inmultiple sclerosis lesions. Am J Pathol 2005; 166: 1143-1151. (Pubitemid 40524438)
37. Wu T, Angus CW, Yao XL, Logun C, Shelhamer JH. P11, a unique memberof the S100 family of calcium-binding proteins, interacts with and inhibits theactivity of the 85-kDa cytosolic phospholipase A2. J Biol Chem 1997; 272:17145-17153. (Pubitemid 27289825)
38. Pawliczak R, Cowan MJ, Huang X, Nanavaty UB, Alsaaty S, Logun C et al. p11expression in human bronchial epithelial cells is increased by nitric oxide in acGMP-dependent pathway involving protein kinase G activation. J Biol Chem2001; 276: 44613-44621.
39. Swisher JF, Burton N, Bacot SM, Vogel SN, Feldman GM. Annexin A2 tetrameractivates human and murine macrophages through TLR4. Blood 2010; 115:549-558.
40. Bayas A, Hummel V, Kallmann BA, Karch C, Toyka KV, Rieckmann P. Human cerebralendothelial cells are a potential source for bioactive BDNF. Cytokine 2002;19: 55-58.
41. Kuno R, Yoshida Y, Nitta A, Nabeshima T, Wang J, Sonobe Y et al. The role of TNFalphaand its receptors in the production of NGF and GDNF by astrocytes. BrainRes 2006; 1116: 12-18. (Pubitemid 44485022)
42. Saha RN, Liu X, Pahan K. Up-regulation of BDNF in astrocytes by TNF-alpha: a casefor the neuroprotective role of cytokine. J Neuroimmune Pharmacol 2006; 1:212-222. (Pubitemid 44244127)
43. Neto FL, Borges G, Torres-Sanchez S, Mico JA, Berrocoso E. Neurotrophins role indepression neurobiology: a review of basic and clinical evidence. Curr Neuropharmacol2011; 9: 530-552.
44. Okuse K, Malik-Hall M, Baker MD, Poon WY, Kong H, Chao MV et al. Annexin II lightchain regulates sensory neuron-specific sodium channel expression. Nature 2002;417: 653-656. (Pubitemid 34614824)
45. Warner-Schmidt JL, Chen EY, Zhang X, Marshall JJ, Morozov A, Svenningsson Pet al. A role for p11 in the antidepressant action of brain-derived neurotrophicfactor. Biol Psychiatry 2010; 68: 528-535.
46. Masiakowski P, Shooter EM. Nerve growth factor induces the genes for twoproteins related to a family of calcium-binding proteins in PC12 cells. Proc NatlAcad Sci USA 1988; 85: 1277-1281. (Pubitemid 18073992)
47. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role ofcytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65:732-741.
48. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and thepathogenesis of depression. Trends Immunol 2006; 27: 24-31. (Pubitemid 43083561)
49. Buffo A, Rite I, Tripathi P, Lepier A, Colak D, Horn AP et al. Origin and progeny ofreactive gliosis: A source of multipotent cells in the injured brain. Proc Natl AcadSci USA 2008; 105: 3581-3586. (Pubitemid 351723595)
50. Vedam-Mai V, van Battum EY, Kamphuis W, Feenstra MG, Denys D, Reynolds BAet al. Deep brain stimulation and the role of astrocytes. Mol Psychiatry 2012; 17:124-131115.